This compound is a pharmaceutical intermediate used in the manufacturing of an ezetimibe analog. It features a complex structure with multiple aromatic rings and a silicon-containing protecting group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-[4-(phenylmethoxy)phenyl]-2-azetidinone
pharmaceutical intermediate
Battery Park City Authority
pharmaceutical intermediate
1-[2-Chloro-1-hydroxy-3-(6-quinolinyl)propyl]-2,5-pyrrolidinedione
pharmaceutical intermediate
4-(3-Amino-1,2,4-triazin-6-yl)-2-fluorobenzonitrile
pharmaceutical intermediate
(1-Methyl-4-piperidinyl)[3-[2-(3-chlorophenyl)ethyl]pyridinyl]methanone hydrochloride
pharmaceutical intermediate
(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-trimethylsilyloxypropyl]-4-(4-phenylmethoxyphenyl)azetidin-2-one
LTGYUNOUVQYNOF-XKKJXBDVSA-N
C[Si](C)(C)O[C@@H](CC[C@@H]1[C@H](N(C1=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)OCC4=CC=CC=C4)C5=CC=C(C=C5)F
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.